• Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Special Offers
Business Intelligence Info
  • Business Intelligence
    • BI News and Info
    • Big Data
    • Mobile and Cloud
    • Self-Service BI
  • CRM
    • CRM News and Info
    • InfusionSoft
    • Microsoft Dynamics CRM
    • NetSuite
    • OnContact
    • Salesforce
    • Workbooks
  • Data Mining
    • Pentaho
    • Sisense
    • Tableau
    • TIBCO Spotfire
  • Data Warehousing
    • DWH News and Info
    • IBM DB2
    • Microsoft SQL Server
    • Oracle
    • Teradata
  • Predictive Analytics
    • FICO
    • KNIME
    • Mathematica
    • Matlab
    • Minitab
    • RapidMiner
    • Revolution
    • SAP
    • SAS/SPSS
  • Humor

Cordio and Rambam Hospital will trial AI that detects coronavirus cases from speech samples

April 1, 2020   Big Data

Cordio Medical today announced that it will begin a clinical trial at Haifa’s Rambam Hospital on an app-based AI system that analyzes speech to diagnose and remotely monitor COVID-19 patients. Assuming it passes scientific muster, the tech could be used to help treat self-quarantined patients who are likely to have COVID-19 but haven’t yet been hospitalized.

Cordio’s COVID-19 solution is built on its existing HearO product, which was developed to remotely monitor patients suffering from heart failure by collecting recordings via mobile devices. Engineers at Cordio adapted it to identify the bilateral pneumonia with edema in the lungs that is characteristic of COVID-19. And the company claims it can detect changes in lung fluids and the onset of inflammation even before patients do.

Cordio says HearO is a “patient-dependent” system, in that the company builds a recording baseline for COVID-19 patients when they’re in stable condition and later measures changes from the baseline using AI algorithms — while anonymizing and privatizing the data. It hopes to eventually detect COVID-19 deterioration within 10-48 hours.

HearO, which hasn’t yet obtained FDA approval, can sense fluid accumulation with a claimed accuracy of over 80%. It’s already in use at 10 medical institutions, including Rambam, Beilinson, Barzilai, Hagalil, and Clalit Health Services.

AI-powered voice diagnostics

Given the triaging that voice diagnostic technologies might be able to perform for health care institutions, the previously niche field is gaining attention.

 Cordio and Rambam Hospital will trial AI that detects coronavirus cases from speech samples

Researchers from Carnegie Mellon and startup Voca.ai released an app they claim can determine whether someone has COVID-19 from a voice recording, and Vocalis Health says it’s working with Israel’s Health Ministry and Directorate for Defense Research and Development to collect “vocal biomarkers” from COVID-19 patients and healthy people to develop a screening technology.

These aren’t without caveats — Benjamin Striner, a graduate student who contributed to the Carnegie Mellon project, cautioned that the app’s accuracy can’t be tested because of a lack of verified data. But preliminary research suggests that AI-powered voice analysis can fairly accurately diagnose other conditions, including post-traumatic stress disorder and high blood pressure. To this end, a team at Mayo Clinic is exploring how AI might be used to detect vocal changes that could be predictive of an outcome, such as stroke, heart attack, concussion, and even Parkinson’s disease.

On the private sector side, Canary Speech has developed and completed clinical trials for vocal diagnostic models targeting Alzheimer’s, Parkinson’s, and depression. Another startup — Corti — sells a product that ingests and analyzes emergency call recordings to help dispatchers identify patients experiencing cardiac arrest. WinterLight Labs, whose platform measures hundreds of vocal biomarkers to determine cognitive impairment and mental health issues, is studying potential clinical applications for Alzheimer’s, dementia, aphasia, and depression.

Cordio Medical was founded in 2013 by Chaim Lotan, along with support from Peregrine Ventures, an Isreal-based venture capital fund for early-stage investments.

Let’s block ads! (Why?)

Big Data – VentureBeat

Cases, Cordio, coronavirus, Detects, from, Hospital, Rambam, samples, SPEECH, Trial
  • Recent Posts

    • Soci raises $80 million to power data-driven localized marketing for enterprises
    • Conversational Platform Trends for 2021
    • The Great Awakening?
    • Another Success Story: McWane
    • The Dynamics 365 Sales Mobile App Helps Salespeople Stay Productive From Anywhere
  • Categories

  • Archives

    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
© 2021 Business Intelligence Info
Power BI Training | G Com Solutions Limited